Search research articles
Contact Us
Filters
Showing results (1-10 of 329) with videos related to
Page
of 33
Sort By:
The Lancet. Neurology
|
January 25, 2005
Donepezil for memory impairment in multiple sclerosis
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 17, 2018
A decline in cognitive function should lead to a change in disease-modifying therapy - Commentary
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 11, 2018
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary
Maria Pia Amato
Neuropediatrics
|
August 23, 2012
Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go
Maria Pia Amato
Expert Opinion on Pharmacotherapy
|
October 6, 2004
Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 13, 2017
The diagnostic dilemma of multiple sclerosis presenting with isolated cognitive and behavioral disorders
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 1, 2022
Reliable change indices for cognitive assessment of patients with multiple sclerosis
Emilio Portaccio, Maria Pia Amato
Expert Review of Neurotherapeutics
|
August 26, 2011
Is there a future for donepezil therapy in the treatment of multiple sclerosis-related cognitive impairment?
Maria Pia Amato, Emilio Portaccio
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 8, 2011
Truly benign multiple sclerosis is rare: let's stop fooling ourselves--yes
Maria Pia Amato, Emilio Portaccio
Expert Review of Neurotherapeutics
|
October 9, 2009
Cognitive dysfunction in multiple sclerosis: current approaches to clinical management
Maria Pia Amato, Valentina Zipoli
Page
of 33
Search research articles
Search
Showing results (1-10 of 329) with videos related to
Sort By:
Page
of 33
The Lancet. Neurology
|
January 25, 2005
Donepezil for memory impairment in multiple sclerosis
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 17, 2018
A decline in cognitive function should lead to a change in disease-modifying therapy - Commentary
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 11, 2018
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary
Maria Pia Amato
Neuropediatrics
|
August 23, 2012
Cognitive and psychosocial issues in pediatric multiple sclerosis: where we are and where we need to go
Maria Pia Amato
Expert Opinion on Pharmacotherapy
|
October 6, 2004
Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 13, 2017
The diagnostic dilemma of multiple sclerosis presenting with isolated cognitive and behavioral disorders
Maria Pia Amato
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 1, 2022
Reliable change indices for cognitive assessment of patients with multiple sclerosis
Emilio Portaccio, Maria Pia Amato
Expert Review of Neurotherapeutics
|
August 26, 2011
Is there a future for donepezil therapy in the treatment of multiple sclerosis-related cognitive impairment?
Maria Pia Amato, Emilio Portaccio
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 8, 2011
Truly benign multiple sclerosis is rare: let's stop fooling ourselves--yes
Maria Pia Amato, Emilio Portaccio
Expert Review of Neurotherapeutics
|
October 9, 2009
Cognitive dysfunction in multiple sclerosis: current approaches to clinical management
Maria Pia Amato, Valentina Zipoli
Page
of 33